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Abstract
Proton translocating NADH:ubiquinone oxidoreductase (complex I) is the largest membrane bound multiprotein complex
of the respiratory chain and the only one for which no molecular structure is available so far. Thus, information on the
mechanism of this central enzyme of aerobic energy metabolism is still very limited. As a new approach to analyze complex I,
we have recently established the strictly aerobic yeast Yarrowia lipolytica as a model system that offers a complete set of
convenient genetic tools and contains a complex I that is stable after isolation. For crystallization of complex I and to obtain
its molecular structure it is a prerequisite to prepare large amounts of highly pure enzyme. Here we present the construction
of his-tagged complex I that for the first time allows efficient affinity purification. Our protocol recovers almost 40% of
complex I present in Yarrowia mitochondrial membranes. Overall, 40^80 mg highly pure and homogeneous complex I can be
obtained from 10 l of an overnight Y. lipolytica culture. After reconstitution into asolectin proteoliposomes, the purified
enzyme exhibits full NADH:ubiquinone oxidoreductase activity, is fully sensitive to inhibition by quinone analogue
inhibitors and capable of generating a proton-motive force. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Proton translocating NADH:ubiquinone oxidore-
ductase, also called complex I, is the ¢rst electron
translocating protein complex of the mitochondrial
respiratory chain. It is one of the biggest and most
complicated membrane bound protein complexes
known, consisting of 43 subunits in mammalian mi-
tochondria [1,2] and of at least 35 subunits in mito-
chondria of fungi like the yeast Yarrowia lipolytica
[3]. Complex I plays an essential role in oxidative
phosphorylation, in which it catalyzes a two electron
transfer from NADH to ubiquinone linked to the
translocation of four protons across the mitochon-
drial membrane [4]. This reaction is the ¢rst step in
generating the proton-motive force which drives ATP
synthesis. Despite the physiological importance of
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complex I and the knowledge of an increasing num-
ber of diseases linked to defects in this enzyme [5,6],
no mechanistic details about the electron pathway
within the protein or the coupling of electron trans-
port to vectorial proton translocation over the mito-
chondrial membrane are known. Little structural in-
formation is available, due to the high complexity
and size of this multi-subunit enzyme. However,
progress has also been hampered by the lack of a
model system in which genetic manipulation can be
achieved easily and which at the same time contains
stable complex I that can be easily isolated to allow
for a broad range of protein chemical, biophysical
and structural studies.
Recently, we have established the obligate aero-
bic yeast Y. lipolytica as a model system to study
mitochondrial complex I [7,8] that meets these re-
quirements [3]. Y. lipolytica o¡ers a complete set
of yeast genetic tools [9], including the convenient
possibility to introduce mutated gene copies on Es-
cherichia coli-Y. lipolytica single copy shuttle plas-
mids.
The e⁄ciency and success of functional and struc-
tural studies with such a large membrane bound
enzyme complex are highly dependent on the avail-
ability of a convenient and fast protocol to ob-
tain homogeneous enzyme on a large preparative
scale at high yield. We have achieved this goal
by deleting the chromosomal copy of the NUGM
gene of Y. lipolytica and reintroducing a plasmid-
borne copy with an added his tag sequence. This
construct allowed for rapid a⁄nity chromatography
on a Ni-NTA column and yielded large amounts of
highly pure and homogeneous complex I in a few
hours.
2. Materials and methods
2.1. Strains
Y. lipolytica strains E129 (MatA, lys11-23, ura3-
302, leu2-270, xpr2-322) and E150 (MatB, his-1,
ura3-302, leu2-270, xpr2-322) were a kind gift from
Prof. C. Gaillardin, INRA, Paris, France. The dip-
loid strain GB1 was produced by mating E129 and
E150. Y. lipolytica genetic techniques were carried
out according to [9].
2.2. Deletion of NUGM, the gene coding for the
30 kDa subunit of Y. lipolytica complex I
The complete NUGM gene of Y. lipolytica (acces-
sion No. AJ249784) has been isolated and sequenced
previously [3]. Clone 1C4 containing a 4.8 kb ge-
nomic DNA insert comprising the entire NUGM
gene in pBluescript SK3 was used as starting point
to construct the nugm : :URA3 deletion allele. First, a
copy of this plasmid, excluding the NUGM open
reading frame, was obtained by inverse PCR using
primers 30-1 (5P-TGGCGAATCGAGAGAGCA-3P,
antisense strand), corresponding to bases 2^19 of
the NUGM open reading frame, and 30-2 (5P-TG-
GGAATGTAGGGTGAGA-3P), starting 45 bases
downstream from the stop codon (Fig. 1). The 6.8
kb PCR product was blunt end ligated to a 1.6 kb
PCR product containing the complete Y. lipolytica
URA3 gene (primers Ura1: 5P-CCCATACATTC-
TTCGTTGGAGG-3P, Ura2: 5P-CGCCATTGGCT-
TCTCTCTCTTGA-3P).
A clone in which the orientation of the URA3
reading frame was opposite to the original NUGM
gene was selected and a 3 kb SalI fragment contain-
ing the URA3 gene, £anked by about 700 bp of
downstream and 500 bp of upstream sequence from
the NUGM locus, was used for transformation of
diploid Y. lipolytica GB1 cells. Sixteen URA3 colo-
nies were selected and screened for homologous re-
combination by PCR using a combination of inward
primers derived from sequences outside of the 3 kb
SalI fragment (30ds, 30us) and outward primers de-
rived from the URA3 sequence (URAds, URAus)
and by Southern blotting (data not shown). The
diploid Y. lipolytica clone NK1 was identi¢ed as a
heterozygous homologous recombinant carrying the
nugm : :URA3 deletion allele and a wild-type NUGM
allele.
2.3. Construction of an expression vector carrying the
gene for a his-tagged 30 kDa subunit
A 3 kb SalI fragment from the genomic clone
containing the NUGM gene was subcloned into the
Y. lipolytica shuttle vector pINA240 [9], bearing a
LEU2 marker gene. Codons for a his tag of six con-
secutive histidines with or without an additional
linker of six consecutive alanines were fused to the
BBABIO 45018 26-2-01
N. Kashani-Poor et al. / Biochimica et Biophysica Acta 1504 (2001) 363^370364
C-terminal end of the NUGM open reading frame by
means of inverse PCR in two steps (Fig. 2). Plasmid
pINA240/NUGM was used as a template for inverse
PCR. The primers were designed to amplify the en-
tire plasmid and to add the his tag codons by extend-
ing the C-terminus in the ¢rst PCR. The sense primer
was P1 (5P-CAT CAT CAC TAG TTG AGA TAG
AGC GAT GCT GG-3P) coding for three histidines
and the stop codon, the antisense primer was P2 (5P-
ATG ATG ATG CTT CTT GCT GCC TTC CTT
C-3P) coding for three additional histidines. By this
strategy, 20 base pairs downstream from the stop
codon were deleted. The 7.8 kb PCR product was
self-ligated over blunt ends as described above.
This construct bearing six histidines at the C-termi-
nus of NUGM was referred to as pNK1.1. In the
next step, pNK1.1 was used as a template for anoth-
er inverse PCR. Following the same strategy as de-
scribed above, codons for a six alanine linker were
introduced in front of the six histidine codons, using
the sense primer P3 (5P-AGC TGC TGC CTT CTT
GTC GCC TTC CTT CTC-3P) coding for three ala-
nines and the antisense primer P4 (5P-GCC GCA
GCC CAT CAT CAT CAT CAT CAC TAG-3P)
coding for three additional alanines. The ¢nal plas-
mid resulting from self-ligation of the PCR product
is referred to as pNK1.2. All constructs were veri¢ed
by DNA sequencing.
2.4. Generation of Y. lipolytica strains containing
his-tagged complex I
Plasmids pNK1.1 and pNK1.2, carrying a modi-
¢ed NUGM gene encoding the 30 kDa subunit with
C-terminally added his tag and his tag/linker exten-
sions, respectively, were transformed into the hetero-
zygous diploid strain NK1 carrying the nugm : :URA3
deletion allele by the PLATE transformation method
[10]. Haploid deletion strains complemented by plas-
mid pNK1.1 or pNK1.2 were obtained through spor-
ulation and random spore analysis and referred to as
NK1.1 and NK1.2, respectively.
Presence of the his tag was demonstrated by West-
ern blotting of mitochondrial membranes using com-
mercially available anti-his tag antibody (Anti-His6
peroxidase conjugate, Sigma) and by two-dimension-
al blue-native gel electrophoresis [11] of mitochon-
drial membranes.
2.5. Measurement of catalytic activity
We used DBQ (n-decylubiquinone) as a substrate
for the determination of dNADH:ubiquinone oxido-
reductase activity. Steady state activity was recorded
on a Shimadzu UV-300 spectrometer in the dual
wavelength mode following dNADH oxidation at
340^400 nm (O= 6.10 mM31 cm31) at 30‡C [12].
To monitor activity during complex I preparation,
dNADH oxidation was measured as described
above, but the arti¢cial electron acceptor HAR (hex-
amineruthenium(III)-chloride) was used because this
activity can be taken as a direct measure for complex
I content [13]. 2 mM HAR and 200 WM dNADH
were used in a bu¡er containing 20 mM Na-HEPES,
pH 8.0, 250 mM sucrose, 2 mM EDTA and 2 mM
NaN3.
For measurement of complex I activity in proteo-
liposomes, dNADH:DBQ activity was assayed in 20
mM Na/MOPS, pH 7.2, 50 mM NaCl, 20 mM KCl,
2 mM KCN.
2.6. A⁄nity puri¢cation of his-tagged complex I from
Y. lipolytica
Y. lipolytica cells were grown overnight at 27‡C in
a 10 l Biostat E fermenter (Braun, Melsungen) in
modi¢ed YPD medium (2.5% glucose, 2% bactopep-
tone, 1% yeast extract) and harvested by centrifuga-
tion for 10 min at 5000Ug and 4‡C. Typically, 700^
800 g of wet cell mass was obtained from 10 l of
culture. Mitochondrial membranes were prepared
from the haploid mutant strains NK1.1 and NK1.2
as described in [14] with the sole modi¢cation that
the sucrose concentration in the bu¡er used to resus-
pend the membranes was raised from 400 mM to 600
mM. This modi¢cation was necessary to obtain larg-
er membrane fragments which could readily be sedi-
mented by centrifugation at 140 000Ug for 1 h, to
free the starting material of Ni2 chelating EDTA.
This procedure yielded about 1^2 g of mitochondrial
protein from 100 g of cells (wet weight) with a spe-
ci¢c dNADH:HAR activity of about 1.2 Wmol min31
mg31.
The pellet was resuspended in 50 mM NaCl, 20
mM Na3BO3; pH 7.2 and adjusted to a concentra-
tion of 20 mg/ml total protein.
4000 mg mitochondrial protein were used in a typ-
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ical preparation. For complete membrane protein ex-
traction, 1 g dodecyl maltoside per gram protein was
added, and 1 mM PMSF was present as protease
inhibitor. The solution was stirred on ice for 5 min
and then centrifuged at 140 000Ug for 1 h. The
supernatant was adjusted to 400 mM NaCl and 65
mM imidazole prior to loading onto the 50 ml Ni-
NTA fast £ow Sepharose column (Pharmacia) equil-
ibrated with 65 mM imidazole, 400 mM NaCl, 0.1%
dodecyl maltoside and 20 mM Na-phosphate, pH
7.2. The column was washed with 120 ml of the
same bu¡er and tagged complex I was eluted with
150 ml of 140 mM imidazole, 400 mM NaCl, 0.1%
dodecyl maltoside and 20 mM Na-phosphate, pH 7.2
at a £ow rate of 160 ml/h. Fractions containing
dNADH:HAR activity were combined and concen-
trated by centrifugation using Centricon 30 car-
tridges (Millipore). This pool was applied to a 21.5
mmU60 cm TSKgel G4000SW column (TosoHaas),
which had been equilibrated with 100 mM NaCl,
1 mM EDTA, 25 mM Na/MOPS, pH 7.2 and
0.05% dodecyl maltoside. Chromatography was per-
formed in a Beckman Biosys2000 FPLC system at a
£ow rate of 120 ml/h in the same bu¡er. The com-
bined peak fractions containing dNADH:HAR ac-
tivity were pooled, concentrated to 10^15 mg/ml pro-
tein as described above and stored in liquid nitrogen.
2.7. Reconstitution of isolated complex I into
proteoliposomes
Puri¢ed Y. lipolytica complex I was reinserted into
liposomal membranes by the detergent removal tech-
nique essentially as described in [15] and [16] using
SM-2 Bio-Beads (Bio-Rad). 10 mg/ml of soybean
lipid (asolectin) was sonicated in 1.6% octyl gluco-
side, 50 mM KCl, 20 mM Tris-Cl, pH 7.4. 200 Wg of
Y. lipolytica complex I were incubated under agita-
tion in 1 ml of the sonicated solution for 15 min. 100
mg of Bio-Beads, pretreated as described in [17],
were added to the mixture; additional 100 mg por-
tions of Bio-Beads were added after 30 min, 90 min
and 150 min of agitation. Eventually, the mixture
was agitated for another 90 min to complete the
detergent removal process. All incubation steps
were performed at 4‡C. The supernatant containing
the complex I proteoliposomes was removed using a
thin pipette, the Bio-Beads were washed again twice
with 1 ml 50 mM KCl, 20 mM Tris-Cl, pH 7.4 and
the combined supernatants were centrifuged at
100 000Ug for 90 min. The pellet was carefully re-
suspended in 50 mM KCl, 20 mM Tris-Cl, pH 7.4 to
a ¢nal volume of 200 Wl.
3. Results and discussion
3.1. Deletion of the chromosomal copy of the NUGM
gene and complementation by gene copies
encoding a his-tagged 30 kDa subunit
The entire reading frame of the NUGM gene was
deleted by homologous recombination using a URA3
marked deletion allele (Fig. 1) in the diploid Y. lipo-
lytica strain GB1. Replicative plasmids carrying the
genomic SalI fragment comprising the NUGM open
reading frame that had been C-terminally extended
by sequences encoding six histidines (pNK1.1) and
six histidines plus an additional six alanine linker
(pNK1.2) were used to transform this heterozygous
deletion strain NK1 (Fig. 2). As a control, a plasmid
carrying the unchanged NUGM gene was also trans-
formed into NK1. Haploid strains carrying only a
plasmid-borne copy of NUGM were obtained
through sporulation and subsequent random spore
analysis.
3.2. Puri¢cation of his-tagged complex I
Both constructs bearing the his tag and the his tag
plus alanine linker exhibited normal expression of
the NUGM gene. Mitochondrial membranes from
Fig. 1. Strategy for chromosomal deletion of the NUGM open
reading frame. Primers 30-1 and 30-2 were used in inverse PCR
to create a deletion for almost the entire NUGM open reading
frame. A PCR product of the URA3 gene was inserted into the
gapped plasmid by blunt end ligation. A 3.0 kb SalI fragment
was transformed into the diploid strain GB1. Primer pairs 30ds/
URAds and 30us/URAus were used to verify homologous re-
combination.
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all complemented deletion strains exhibited levels of
dNADH:ubiquinone oxidoreductase activity similar
to the parental strain (data not shown). The addi-
tional amino acids did not interfere with the as-
sembly of the multi-subunit enzyme and no sub-
complexes of complex I were detectable by two-
dimensional blue-native electrophoresis (data not
shown). Western blotting using anti-his tag antibody
revealed that the size of the 30 kDa was increased as
expected (data not shown) and that the tags were
markedly stable against proteases, as apart from
the addition of PMSF no special measures were
needed to prevent proteolytic digestion.
Application of total mitochondrial membranes ex-
tracted with 1 g/g of dodecyl maltoside to Ni-NTA
columns revealed that both tags were accessible to
the resin and bound with high a⁄nity. Experience
showed that complex I from NK1.2, possessing the
his tag with the six alanine linker, would bind slightly
tighter to the Ni-NTA column and allowed a wash
step with 65 mM imidazole while NK1.1 started to
elute under these conditions (data not shown). Ob-
viously, the six additional alanines added in front of
the histidines improved accessibility of the tag to the
column. Since washing with 65 mM imidazole signif-
icantly improved the purity of the preparation,
NK1.2 was used and ^ if not stated otherwise ^
only results obtained with this strain will be dis-
cussed in the following.
An average of 80^90% of complex I in the total
extract bound to the Ni-NTA column and eluted
at 140 mM imidazole as a single peak. The pooled
fractions had a speci¢c dNADH:HAR activity
of around 35 Wmol min31 mg31 corresponding to a
20-fold enrichment of complex I by this single step.
The Ni-NTA pool was concentrated and loaded onto
a TSK G4000 column for further puri¢cation and
removal of imidazole. The latter was also required
for EPR spectroscopic analysis, as high concentra-
tions of imidazole were found to lead to reoxidation
of all iron-sulfur clusters but N2 in samples previ-
ously reduced with NADH. Complex I eluted as a
symmetric from the TSKgel G4000W column (not
shown). Contaminations still present after a⁄nity
chromatography could be removed by this step.
With high reproducibility, the TSKgel G4000W
pool exhibited a dNADH:HAR activity of around
65 Wmol min31 mg31, which means that complex I
was enriched 70-fold as compared to mitochondrial
membranes (Table 1). Overall, starting with around
Table 1
Puri¢cation of his-tagged Y. lipolytica complex I from strain NK1.2
Fraction Protein dNADH:HAR activity Yield (%)
mg % Wmol min31 Wmol min31 mg31
Membranes 4000 100 3540 0.9 100
Lauryl maltoside extract 1700 42 2670 1.6 76
Ni-NTA pool 43 1.1 1520 32 43
TSKgel G4000SW pool 19 0.5 1350 64 38
Fig. 2. Construction of expression vectors pNK1.1 and
pNK1.2. pINA 240/NUGM was used as template for inverse
PCR. Primer 1 coded for three histidines and the stop codon,
primer 2 for three histidines as extensions. The self-ligated
product of this PCR is referred to as pNK1.1 and was used as
a template for the construction of pNK1.2. Extensions of prim-
ers 3 and 4 each coded for three alanines. bla, L-lactamase
gene; Y. lipolytica chromosomal ARS18, ARS/CEN region (ac-
cession No. M91600); tet, tetracycline resistance gene.
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4000 mg of mitochondrial membranes, 18^20 mg of
highly pure complex I could be isolated by a highly
reproducible two step protocol (Table 1). Thus, com-
pared to the conventional protocol [3], his tag a⁄nity
puri¢cation of complex I cuts down the preparation
time by half (down to about 7 h) and yields 2^3 times
more enzyme of signi¢cantly higher purity.
3.3. Properties of puri¢ed his-tagged complex I
Comparison of puri¢ed his-tagged complex I with
conventionally puri¢ed [3] wild-type enzyme by tri-
cine SDS-PAGE [18] demonstrated the much higher
purity of the a⁄nity puri¢ed enzyme and also con-
¢rmed complete assembly (Fig. 3). Less than 2% of
cytochrome oxidase as very minor contaminant
could be detected by UV spectroscopy. The increased
size of the 30 kDa subunit also demonstrated that
both variants of the his tag had remained stable in
the complex during the puri¢cation procedure.
No signi¢cant di¡erences of other features were
observed in comparison to conventionally puri¢ed
complex I from Y. lipolytica [3] : EPR spectra of
the reduced iron-sulfur clusters were found to be
identical (K. Zwicker et al., unpublished) and nega-
tive stain images of single particles showed a homo-
geneous population of L-shaped molecules (M. Ra-
dermacher et al., unpublished). These observations
not only demonstrated the structural integrity of pu-
ri¢ed complex, but also con¢rmed the higher purity
and homogeneity of Y. lipolytica complex I puri¢ed
by a⁄nity chromatography.
Like complex I puri¢ed from Y. lipolytica [3] and
other sources [19,20] by conventional methods, the
puri¢ed his-tagged enzyme exhibited only a very
low speci¢c dNADH:ubiquinone oxidoreductase ac-
tivity of 0.1 Wmol min31 mg31. Already upon addi-
tion of detergent for total extraction, we observed a
2^3-fold decrease of DBQ reductase activity. How-
ever, the loss of activity was almost fully reversible
by reconstitution of the puri¢ed complex into asolec-
tin proteoliposomes (see below).
3.4. Reconstitution of complex I into proteoliposomes
Puri¢ed, his-tagged complex I was reconstituted
into proteoliposomes by the detergent removal meth-
od. Using the dNADH:HAR oxidoreductase activity
as a measure for complex I content we estimated that
15^20% of added complex I was recovered in the
proteoliposomes. dNADH:HAR oxidoreductase ac-
tivity was also used to determine the orientation of
complex I in the liposomal membrane. We found
that 80^90% of the NADH binding sites were acces-
sible already in sealed proteoliposomes, the remain-
ing complexes becoming accessible after permeabili-
zation of the membranes by the addition of 0.1%
CHAPS during the assay. This indicated that the
majority of the complex I molecules were oriented
inside-out when compared to mitochondria.
Fig. 3. SDS-PAGE of puri¢ed complex I. Tricine SDS-PAGE
of puri¢ed complex I on a 16% gel was performed according to
[18]. The increased size of the 30 kDa subunit (arrow) due to
the addition of a his tag (lane B) and a his tag plus alanine
linker (lane C) is clearly visible. Lanes: A, 7 Wg of convention-
ally puri¢ed complex I [3] ; B, 5 Wg of a⁄nity puri¢ed complex
I from strain NK1.1; C, 7 Wg of a⁄nity puri¢ed complex I
from strain NK1.2.
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dNADH:ubiquinone oxidoreductase activity of
complex I in proteoliposomes was stimulated 6^7-
fold upon uncoupling with 2 WM valinomycin and
2 WM CCCP (Fig. 4). As this indicated the genera-
tion of a proton-motive force, we conclude that pu-
ri¢ed tagged complex I was capable of translocating
protons across the liposomal membrane.
When soybean asolectin was used for reconstitu-
tion, the dNADH:ubiquinone oxidoreductase turn-
over number recovered essentially to the value calcu-
lated for mitochondrial membranes: reconstitution
into asolectin proteoliposomes increased the speci¢c
dNADH:ubiquinone oxidoreductase activity more
than 60-fold from 0.1 Wmol min31 mg31 for isolated
complex I to 6.7 Wmol min31 mg31 in uncoupled,
permeabilized proteoliposomes (Fig. 4), correspond-
ing to a turnover number of about 100 s31. This
activity could be inhibited completely by the addition
of 2 WM DQA during the assay. It should be noted
that almost no stimulation of DBQ reductase activity
was observed when egg yolk phospholipid rather
than asolectin was used for reconstitution.
4. Conclusions
Attaching a his tag and a linker of six alanine
residues to the C-terminus of the 30 kDa subunit
of complex I for the ¢rst time allowed a⁄nity puri-
¢cation of this membrane bound 900 kDa multipro-
tein complex. The high cell yield of Y. lipolytica, its
constitutively high content of mitochondria and a
complex I recovery of almost 40% by the puri¢cation
protocol described here result in an overall yield of
40^80 mg of a fully assembled, highly pure and ho-
mogeneous preparation of this enzyme complex from
10 l of overnight culture. Following reconstitution
into proteoliposomes the puri¢ed enzyme exhibits
full, inhibitor sensitive activity and is capable of gen-
erating a proton-motive force. Thus, a⁄nity puri¢ed
complex I seems very well suited for crystallization
attempts aimed at eventually resolving the molecular
structure of mitochondrial complex I.
Acknowledgements
We thank Klaus Zwicker and Hermann Scha«gger
for carefully reading the manuscript and helpful dis-
cussions. Expert technical assistance from Jolanta
Broszka and Franz J. Streb is gratefully acknowl-
edged. This work was supported by grant SFB 472-
P2 from the Deutsche Forschungsgemeinschaft and
by the Fond der Chemischen Industrie.
References
[1] J.E. Walker, J.M. Skehel, S.K. Buchanan, Methods Enzy-
mol. 260 (1995) 14^34.
[2] J.M. Skehel, I.M. Fearnley, J.E. Walker, FEBS Lett. 438
(1998) 301^305.
[3] R. Djafarzadeh, S. Kerscher, K. Zwicker, M. Radermacher,
M. Lindahl, H. Scha«gger, U. Brandt, Biochim. Biophys.
Acta 1459 (2000) 230^238.
[4] M.K.F. Wikstro«m, Nature 308 (1984) 558^560.
[5] A.H. Schapira, Biochim. Biophys. Acta 1364 (1998) 261^270.
Fig. 4. dNADH:ubiquinone oxidoreductase activity of complex
I puri¢ed from strain NK1.2 reconstituted into asolectin proteo-
liposomes. dNADH:DBQ oxidoreductase activities of 3.3 Wg
complex I in proteoliposomes were measured in the presence of
saturating concentrations of substrates (100 WM dNADH, 60
WM DBQ). The reaction was started by the addition of DBQ.
2 WM valinomycin (Val), 2 WM CCCP and 2 WM DQA were
added as indicated. Rates are indicated as speci¢c activities
(Wmol min31 mg31).
BBABIO 45018 26-2-01
N. Kashani-Poor et al. / Biochimica et Biophysica Acta 1504 (2001) 363^370 369
[6] B.H. Robinson, Biochim. Biophys. Acta 1364 (1998) 271^
286.
[7] P. Ahlers, K. Zwicker, S. Kerscher, U. Brandt, J. Biol.
Chem. 275 (2000) 23577^23582.
[8] P. Ahlers, A. Garofano, S. Kerscher, U. Brandt, Biochim.
Biophys. Acta 1459 (2000) 258^265.
[9] G. Barth, C. Gaillardin, in: K. Wolf (Ed.), Non-convention-
al Yeasts in Biotechnology, Springer, Berlin, 1996, pp. 313^
388.
[10] R. Elble, BioTechniques 13 (1992) 18^20.
[11] H. Scha«gger, G. von Jagow, Anal. Biochem. 199 (1991) 223^
231.
[12] J.G. Okun, P. Lu«mmen, U. Brandt, J. Biol. Chem. 274
(1999) 2625^2630.
[13] V.D. Sled, A.D. Vinogradov, Biochim. Biophys. Acta 1141
(1993) 262^268.
[14] S. Kerscher, J.G. Okun, U. Brandt, J. Cell Sci. 112 (1999)
2347^2354.
[15] J.-L. Rigaud, B. Pitard, R.M. Levy, Biochim. Biophys. Acta
1231 (1995) 223^246.
[16] M.L. Verkhovskaya, A. Garcia-Horsman, A. Puustinen,
J.-L. Rigaud, J.E. Morgan, M.I. Verkhovsky, M.K.F.
Wikstro«m, Proc. Natl. Acad. Sci. USA 94 (1997) 10128^
10131.
[17] P.W. Holloway, Anal. Biochem. 53 (1973) 304^307.
[18] H. Scha«gger, G. von Jagow, Anal. Biochem. 166 (1987) 368^
379.
[19] S.K. Buchanan, J.E. Walker, Biochem. J. 318 (1996) 343^
349.
[20] J.G. Okun, V. Zickermann, K. Zwicker, H. Scha«gger, U.
Brandt, Biochim. Biophys. Acta 1459 (2000) 77^87.
BBABIO 45018 26-2-01
N. Kashani-Poor et al. / Biochimica et Biophysica Acta 1504 (2001) 363^370370
